The Consumer Product Safety Commission (CPSC) of the United States government has been strictly regulating the Indian pharmaceutical industry due to continuous drug violations. In The American Bazaar’s report last August 2014, another Indian pharmaceutical company, Dr. Reddy’s Laboratories, allegedly violated packaging rules for some of their manufactured prescription drugs exported to the United States from 2008 to 2012.
Since 2013, the U.S. Food and Drug Administration (FDA) has recorded over a dozen of Indian pharmaceutical firms, resulting in a huge number of product recalls and complete banning of drug imports to the country. In addition, the FDA sent a warning letter to Marck Biosciencies, another Indian manufacturer, for committing fraud as they exploited FDA’s data in order to proceed with their operation despite recorded deficiencies in both their drugs and facilities.
A number of Indian factories managed to get away with these cases, as they continue to receive favorable results with relation to their sales. As producers of generic medicines, they focus on providing people cheap alternatives that can cure their illnesses, but are not necessarily of high quality. From exporting products to Europe and North America, they have expanded on different parts of the globe targeting countries that have high demands for inexpensive medicines.
What’s more is that according to several researchers, India doesn’t have a regulatory system to oversee unlawful practices, which has so far made it easier for them to escape. This incompetence can be linked with having under-trained officials simultaneously. Presently, the FDA now has an office in India in their purpose of monitoring operations of the different facilities all around the country.
Defective Drugs Law
Patients prescribed with defective drugs may file corresponding lawsuits against the manufacturer, laboratory, physician, or anyone belonging to the pharmaceutical industry that can be held liable for the damaging effects of the medicine. For this purpose, the patient would need the guidance of an experienced Brooklyn personal injury attorney well versed on medical malpractice cases, like those from The Law Office of Joseph Lichtenstein.
Taking defective drugs may result to allergic or counter-productive reactions, much to the detriment of the patient. A knowledgeable personal injury lawyer in Brooklyn assists defective drugs victims in determining which specific type of suit to file against the industry under the Medical Malpractice Law and/or the Defective Drugs Law following the Product Liability Law.
Upon proving that prescribed medicines are defective or contaminated, the attorney then discusses the appropriate claim as grounded on different classifications—namely manufacturing defects, design defects, and failure to warn (defective marketing)—to provide legal counsel for clients suffering from usage of defective drugs.
(Source: India’s pharma continues to face heat from the US: now it’s Dr. Reddy’s Laboratories turn, American Bazaar Online)